Budget impact of intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency in France

AIMS: This analysis aims to evaluate the budget impact of intravenous iron therapy with ferric carboxymaltose for patients with systolic chronic heart failure and iron deficiency, from the perspective of the French public health insurance. METHODS AND RESULTS: A budget impact model was adapted to fo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:ESC Heart Fail
Autori principali: Bourguignon, Sandrine, Faller, Mathilde, Champs, François‐Olivier, Moutier, Hélène, Levesque, Karine, Caranhac, Gilbert, Cohen‐Solal, Alain
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Original Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487717/
https://ncbi.nlm.nih.gov/pubmed/31021531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12432
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi